FDA accepts BLA from AstraZeneca and Daiichi for targeted chemotherapy
AstraZeneca and Daiichi Sankyo have announced that the US Food and Drug Administration (FDA) has...
AstraZeneca and Daiichi Sankyo have announced that the US Food and Drug Administration (FDA) has...